However, DUSP6 mRNA expression was neither a prognostic factor in Luminal B or Basal subtypes, nor across unselected breast cancer patient population (Appendix Fig. S2E), further highlighting the selective connection between DUSP6 and HER2 in breast cancer progression. This evidence concerns the gene ERBB2 and breast cancer.